Copyright
©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Sep 5, 2022; 13(5): 77-87
Published online Sep 5, 2022. doi: 10.4292/wjgpt.v13.i5.77
Published online Sep 5, 2022. doi: 10.4292/wjgpt.v13.i5.77
Table 1 Patient demographics
| All (N = 154) | PEG ≤ 7 d (N = 62, 40.26%) | PEG > 7 d (N = 92, 59.74%) | P value | ||||
| N | SD | N | SD | N | SD | ||
| Age | 69.62 | 15.02 | 74.65 | 13.89 | 66.24 | 14.87 | 0.00051 |
| Sex | 0.0658 | ||||||
| Female | 78 | 50.65 | 37 | 59.68 | 41 | 44.57 | |
| Male | 76 | 49.35 | 25 | 40.32 | 51 | 55.43 | |
| Any comorbidity | 147 | 95.45 | 59 | 95.16 | 88 | 95.65 | 1.00002 |
| Number of comorbidities | 0.43393 | ||||||
| 0 | 7 | 4.55 | 3 | 4.84 | 4 | 4.35 | |
| 1 | 26 | 16.88 | 12 | 19.35 | 14 | 15.22 | |
| 2 | 37 | 24.03 | 13 | 20.97 | 24 | 26.09 | |
| 3 | 41 | 26.62 | 17 | 27.42 | 24 | 26.09 | |
| 4 | 26 | 16.88 | 12 | 19.35 | 14 | 15.22 | |
| 5 | 8 | 5.19 | 4 | 6.45 | 4 | 4.35 | |
| 6 | 5 | 3.25 | 0 | 0.00 | 5 | 5.43 | |
| 7 | 3 | 1.95 | 1 | 1.61 | 2 | 2.17 | |
| 8 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | |
| 9 | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | |
Table 2 Patient comorbidities
| Types of comorbidities | All (N = 154) | PEG ≤ 7 d (N = 62, 40.26%) | PEG > 7 d (N = 92, 59.74%) | P value | |||
| N | % | N | % | N | % | ||
| Acute respiratory distress syndrome | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Acute kidney injury | 2 | 1.30 | 0 | 0.00 | 2 | 2.17 | 0.5158 |
| Alcohol abuse | 5 | 3.25 | 2 | 3.23 | 3 | 3.26 | 1.00001 |
| Amyotrophic lateral sclerosis | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Anemia | 4 | 2.60 | 2 | 3.23 | 2 | 2.17 | 1.00001 |
| Aortic dissection | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Aortic stenosis | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Arrhythmias | 7 | 4.55 | 4 | 6.45 | 3 | 3.26 | 0.44031 |
| Atrial fibrillation | 32 | 20.78 | 17 | 27.42 | 15 | 16.30 | 0.0955 |
| Breast cancer | 3 | 1.95 | 2 | 3.23 | 1 | 1.09 | 0.56521 |
| Coronary artery disease | 29 | 18.83 | 9 | 14.52 | 20 | 21.74 | 0.2609 |
| Cirrhosis | 1 | 0.65 | 1 | 1.61 | 0 | 0.00 | 0.40261 |
| Chronic kidney disease | 14 | 9.09 | 2 | 3.23 | 12 | 13.04 | 0.0377 |
| Colon cancer | 2 | 1.30 | 2 | 3.23 | 0 | 0.00 | 0.16051 |
| Chronic obstructive pulmonary disease | 9 | 5.84 | 1 | 1.61 | 8 | 8.70 | 0.08531 |
| Dementia | 15 | 9.74 | 5 | 8.06 | 10 | 10.87 | 0.5648 |
| Diabetes mellitus | 52 | 33.77 | 19 | 30.65 | 33 | 35.87 | 0.5014 |
| Deep vein thrombosis | 1 | 0.65 | 1 | 1.61 | 0 | 0.00 | 0.40261 |
| Heart failure | 24 | 15.58 | 11 | 17.74 | 13 | 14.13 | 0.5445 |
| Hyperlipidemia | 45 | 29.22 | 20 | 32.26 | 25 | 27.17 | 0.4963 |
| Hypertension | 121 | 78.57 | 45 | 72.58 | 76 | 82.61 | 0.1369 |
| Lung cancer | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Nonalcoholic steatohepatitis | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Obstructive sleep apnea | 3 | 1.95 | 1 | 1.61 | 2 | 2.17 | 1.00001 |
| Peripheral artery disease | 6 | 3.90 | 5 | 8.06 | 1 | 1.09 | 0.03911 |
| Parkinson's disease | 2 | 1.30 | 0 | 0.00 | 2 | 2.17 | 0.51581 |
| Patent Foramen Ovale | 1 | 0.65 | 1 | 1.61 | 0 | 0.00 | 0.40261 |
| Prostate cancer | 2 | 1.30 | 0 | 0.00 | 2 | 2.17 | 0.51581 |
| Pulmonary hypertension | 1 | 0.65 | 1 | 1.61 | 0 | 0.00 | 0.40261 |
| Seizure disorder | 4 | 2.60 | 2 | 3.23 | 2 | 2.17 | 1.00001 |
| Stroke | 38 | 24.68 | 14 | 22.58 | 24 | 26.09 | 0.62061 |
| Substance abuse | 1 | 0.65 | 0 | 0.00 | 1 | 1.09 | 1.00001 |
| Thrombocytopenia | 2 | 1.30 | 1 | 1.61 | 1 | 1.09 | 1.00001 |
| Thyroid cancer | 1 | 0.65 | 1 | 1.61 | 0 | 0.00 | 0.40261 |
Table 3 Mortality and complications in percutaneous endoscopic gastrostomy tubes placed ≤ 7 d vs > 7 d post stroke
Table 4 Types of peri-procedural and post procedural complications
| Early PEG group | Late PEG group | Analysis value (P) Fisher’s exact | |
| Peri procedural complication | |||
| Pulled PEG tube | 0 | 1 | 1 |
| Pulmonary edema | 0 | 1 | 1 |
| NSTEMI | 0 | 1 | 1 |
| Bleeding | 0 | 4 | 0.15 |
| Pneumonia | 1 | 1 | 1 |
| Evolving stroke/herniation | 1 | 0 | 0.4 |
| Post procedural complications | |||
| Aspiration | 8 | 14 | 0.69 |
| Pneumonia | 10 | 16 | 0.84 |
| Bleeding | 2 | 2 | 1 |
| Buried bumper | 1 | 0 | 0.4 |
| Cardiac arrest | 2 | 1 | 0.57 |
| Death | 7 | 8 | 0.59 |
| Ileus | 0 | 1 | 1 |
| Infection | 5 | 4 | 0.49 |
| Necrotizing pancreatitis | 0 | 1 | 1 |
| Pulled PEG tube | 3 | 9 | 0.36 |
| Pulmonary embolism | 0 | 3 | 0.27 |
| Respiratory failure | 1 | 3 | 0.65 |
| Seroma | 1 | 0 | 0.4 |
| Stroke | 1 | 2 | 1 |
Table 5 Predictors of mortality: Multivariate logistic regression analysis
| Death in 30 d, OR [95%CI] | Death in 90 d, OR [95%CI] | Peri-procedural complication, OR [95%CI] | Post-procedural complications, OR [95%CI] | |
| Protein calorie malnutrition (albumin ≤ 3.2) | 0.757 [0.179-3.21] | 0.854 [0.289-2.527] | 1.31 [0.37-4.7] | 1.07 [0.54-2.11] |
| Documented SIRS criteria or infection pre-procedure | 0.524 [0.06-4.52] | 0.56 [0.12-2.67] | 1.55 [0.38-6.28] | 1.92 [0.85-4.35] |
| Presence of cardiovascular risk equivalent independent of this stroke | 0.24 [0.05-1.24] | 0.35 [0.11-1.09] | 0.65 [0.19-2.23] | 1.63 [0.82-3.24] |
- Citation: Reddy KM, Lee P, Gor PJ, Cheesman A, Al-Hammadi N, Westrich DJ, Taylor J. Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes. World J Gastrointest Pharmacol Ther 2022; 13(5): 77-87
- URL: https://www.wjgnet.com/2150-5349/full/v13/i5/77.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v13.i5.77
